Compare XCUR & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XCUR | TOMZ |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 12.5M |
| IPO Year | 2017 | 2009 |
| Metric | XCUR | TOMZ |
|---|---|---|
| Price | $2.60 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.9K | ★ 231.2K |
| Earning Date | 03-25-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.37 | 13.64 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,635,927.00 |
| Revenue This Year | N/A | $48.56 |
| Revenue Next Year | N/A | $121.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.71 | $0.50 |
| 52 Week High | $9.50 | $1.20 |
| Indicator | XCUR | TOMZ |
|---|---|---|
| Relative Strength Index (RSI) | 36.99 | 47.75 |
| Support Level | $1.71 | $0.69 |
| Resistance Level | $3.40 | $0.82 |
| Average True Range (ATR) | 0.38 | 0.10 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 39.60 | 29.44 |
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. The product portfolio of the company includes The SteraPak, The Surface Unit, SteraMist Transport, The NV+, The Environment System, and others.